1y return+40.3%S&P 500 +20.9%
3y return+76.9%S&P 500 +68.5%
5y return+29.6%S&P 500 +74.5%
10y return+246.4%S&P 500 +256.5%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since June 30, 2016: $346 against $357 in the S&P 500.2
683 Capital Management, LLCS&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| COFCapital One Finl Corp | $73.2M | 7.0% | −2.7% |
| CVNACarvana Co | $49.4M | 4.7% | −3.2% |
| ANABAnaptysbio Inc | $44.6M | 4.3% | +5.6% |
| KSPIKaspi Kz Jsc | $40.7M | 3.9% | −1.1% |
| BDXBecton Dickinson & Co | $37.8M | 3.6% | +11.1% |
| MOHMolina Healthcare Inc | $37.7M | 3.6% | +3.1% |
| HGVHilton Grand Vacations Inc | $36.1M | 3.5% | −11.0% |
| PTGXProtagonist Therapeutics Inc | $35.5M | 3.4% | −18.3% |
| Meiragtx Hldgs PLCCUSIP G59665102 | $31.1M | 3.0% | −6.1% |
| Wave Life Sciences LtdCUSIP Y95308105 | $28.8M | 2.8% | +1.0% |
| Uniqure NvCUSIP N90064101 | $26.5M | 2.5% | +15.0% |
| AMLXAmylyx Pharmaceuticals Inc | $23.0M | 2.2% | −16.4% |
| AMTMAmentum Holdings Inc | $22.7M | 2.2% | +41.9% |
| TGTXTg Therapeutics Inc | $21.4M | 2.1% | −34.1% |
| PHATPhathom Pharmaceuticals Inc | $20.1M | 1.9% | |
| UUnity Software Inc | $17.6M | 1.7% | New |
| WALWestern Alliance Bancorp | $16.4M | 1.6% | −11.1% |
| IAGIamgold Corp | $16.0M | 1.5% | −3.8% |
| ELVElevance Health Inc Formerly | $15.5M | 1.5% | |
| TRAXFirst Tracks Biotherapeutics | $15.1M | 1.4% | New |
| Knot Offshore Partners LPCUSIP Y48125101 | $15.0M | 1.4% | +1.7% |
| SRPTSarepta Therapeutics Inc | $14.1M | 1.4% | +4.3% |
| UNHUnitedhealth Group Inc | $13.3M | 1.3% | |
| SESea Ltd | $12.9M | 1.2% | New |
| GOOGLAlphabet Inc | $12.5M | 1.2% | −2.8% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| PTGXProtagonist Therapeutics Inc | December 31, 2022 | +1023.6% | $35.5M |
| AMLXAmylyx Pharmaceuticals Inc | June 30, 2024 | +845.3% | $23.0M |
| CVNACarvana Co | September 30, 2023 | +683.9% | $49.4M |
| ARISAris Mining Corporation | September 30, 2023 | +556.8% | $11.5M |
| ANABAnaptysbio Inc | March 31, 2025 | +263.1% | $44.6M |
| WALWestern Alliance Bancorp | June 30, 2023 | +125.4% | $16.4M |
| ZVRAZevra Therapeutics Inc | December 31, 2023 | +118.9% | $12.3M |
| IAGIamgold Corp | June 30, 2025 | +115.5% | $16.0M |
| GOOGLAlphabet Inc | June 30, 2025 | +102.8% | $12.5M |
| COFCapital One Finl Corp | June 30, 2022 | +92.5% | $73.2M |
Sold off last quarter
- LLYEli Lilly & Co was $13.8M
- Amicus TherapeuticCUSIP 03152W109 was $11.2M
- Apellis Pharmaceuticals IncCUSIP 03753U106 was $10.1M
- LEN/BLennar Corp was $9.7M
- BKNGBooking Holdings Inc was $9.3M
- CCOICogent Comm Holdings Inc was $8.5M
- GSATGlobalstar Inc was $6.5M
- Perceptive Cap Solutions CorCUSIP G70077105 was $6.2M
- VKTXViking Therapeutics Inc was $4.2M
- Theravance Biopharma IncCUSIP G8807B106 was $4.1M
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +14.2% | +14.8% |
| March 31, 2026 | −7.0% | −4.6% |
| December 31, 2025 | +12.5% | +2.4% |
| September 30, 2025 | +17.4% | +7.8% |
| June 30, 2025 | +9.8% | +10.5% |
| March 31, 2025 | −8.6% | −4.6% |
| December 31, 2024 | −2.7% | +2.1% |
| September 30, 2024 | +11.5% | +5.4% |
| June 30, 2024 | −3.3% | +4.0% |
| March 31, 2024 | +12.8% | +10.0% |
| December 31, 2023 | +8.5% | +11.2% |
| September 30, 2023 | −2.1% | −3.6% |
| June 30, 2023 | +10.0% | +8.3% |
| March 31, 2023 | +4.3% | +7.0% |
| December 31, 2022 | +6.8% | +7.1% |
| September 30, 2022 | −1.1% | −5.3% |
| June 30, 2022 | −17.9% | −16.5% |
| March 31, 2022 | −13.2% | −4.9% |
| December 31, 2021 | −6.5% | +10.7% |
| September 30, 2021 | −9.4% | +0.3% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: 683 Capital Management, LLC Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1404574&type=13F-HR&dateb=&owner=include&count=40CIK 1404574
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1404574/000140457426000023/Filed August 14, 2026 · accession 0001404574-26-000023